✦ LIBER ✦

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study

✍ Scribed by Yuichi Inoue; Koichi Hirata; Kenji Kuroda; Masahiko Fujita; Tetsuo Shimizu; Narutsugu Emura; Naohisa Uchimura; Tatsuo Kagimura; Koji Sha; Taneyoshi Nozawa

Book ID: 116884716
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 212 KB
Volume: 11
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2009.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTRO

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFICACY AND SAFETY OF GABAPENTIN ENACARBIL IN JAPANESE PATIENTS WITH PRIMARY RESTLESS LEGS SYNDROME

✍ Yuichi Inoue; Naohisa Uchimura; Kenji Kuroda; Koichi Hirata; Nobutaka Hattori 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy and safety of pramipexole in ch

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: Results from a multi-center, randomized, double-blind, placebo-controlled trial

✍ Jian-Fang Ma; Qi Wan; Xin-Yue Hu; Sheng-Gang Sun; Wei-Zhi Wang; Zhong-Xin Zhao; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Efficacy of oral iron in patients with r

Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study

✍ James Wang; Brian O’Reilly; Ramesh Venkataraman; Vincent Mysliwiec; Angela Mysli 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Efficacy of pramipexole in restless legs

Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)

✍ Wolfgang H. Oertel; Karin Stiasny-Kolster; Bettina Bergtholdt; Yngve Hallström; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract We evaluated the efficacy of pramipexole versus placebo in restless legs syndrome (RLS) for 6 weeks. Overall, 345 patients were randomly assigned in a 1:2 ratio to receive either placebo (n = 115) or pramipexole (n = 230) with a starting dose of 0.125 mg/day. The dose was individually o

Efficacy and safety of pramipexole in id

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study

✍ Markku Partinen; Kari Hirvonen; Leni Jama; Anniina Alakuijala; Christer Hublin; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Efficacy and tolerability of sumanirole

Efficacy and tolerability of sumanirole in restless legs syndrome: A phase II, randomized, double-blind, placebo-controlled, dose–response study

✍ Diego Garcia-Borreguero; John Winkelman; Alieu Adams; Amanda Ellis; Mark Morris; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 239 KB